| dc.contributor.author | Zhao, Sizheng Steven | |
| dc.contributor.author | Jones, Gareth | |
| dc.contributor.author | Macfarlane, Gary | |
| dc.contributor.author | Hughes, David M | |
| dc.contributor.author | Moots, Robert J | |
| dc.contributor.author | Goodson, Nicola J | |
| dc.date.accessioned | 2022-02-01T17:11:01Z | |
| dc.date.available | 2022-02-01T17:11:01Z | |
| dc.date.issued | 2021-09-30 | |
| dc.identifier.citation | Zhao , S S , Jones , G , Macfarlane , G , Hughes , D M , Moots , R J & Goodson , N J 2021 , ' Comorbidity and response to TNF inhibitors in axial spondyloarthritis : longitudinal analysis of the BSRBR-AS ' , Rheumatology , vol. 60 , no. 9 , keaa900 , pp. 4158–4165 . https://doi.org/10.1093/rheumatology/keaa900 | en |
| dc.identifier.issn | 1462-0324 | |
| dc.identifier.other | PURE: 180898318 | |
| dc.identifier.other | PURE UUID: 4bfdcfe4-ac2b-4888-9237-f7f7ef644f71 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/88320309 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/88320710 | |
| dc.identifier.other | PubMed: 33369676 | |
| dc.identifier.other | Scopus: 85116957851 | |
| dc.identifier.other | WOS: 000710982100044 | |
| dc.identifier.uri | https://hdl.handle.net/2164/18015 | |
| dc.description | Acknowledgements: Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it. Disclosures: The authors declare no conflicts of interest. Contribution: SSZ analysed the data and wrote the manuscript, with significant input from all coauthors. GJM and GTJ are Chief Investigator and Deputy Chief Investigator respectively on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Data availability: Data from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis are available to external investigators, on reasonable request. For information on how to access data, see: http://www.rheumatology.org.uk. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: www.abdn.ac.uk/bsrbr-as | en |
| dc.format.extent | 8 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Rheumatology | en |
| dc.rights | © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | en |
| dc.subject | axial spondyloarthritis | en |
| dc.subject | comorbidities | en |
| dc.subject | treatment response | en |
| dc.subject | TNF inhibitors | en |
| dc.subject | ankylosing spondylitis | en |
| dc.subject | R Medicine | en |
| dc.subject | Other | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Comorbidity and response to TNF inhibitors in axial spondyloarthritis : longitudinal analysis of the BSRBR-AS | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Vice Principals | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1093/rheumatology/keaa900 | |
| dc.identifier.vol | 60 | en |
| dc.identifier.iss | 9 | en |
